Status:
COMPLETED
Moringa Oleifera- Antiretroviral Pharmacokinetic Drug Interaction
Lead Sponsor:
University of Zimbabwe
Collaborating Sponsors:
State University of New York at Buffalo
Biomedical Research and Training Institute
Conditions:
HIV
Eligibility:
All Genders
18+ years
Brief Summary
A study will be conducted by scientists from the University of Zimbabwe to determine if antiretroviral drugs are affected by taking herbs at the same time. This is important because herbal medicines m...
Detailed Description
The use of herbal supplements is widespread in Africa, particularly for the management of HIV and AIDS. In Zimbabwe, the prevalence of herbal medicine use in HIV-infected people is as high as 79% (Seb...
Eligibility Criteria
Inclusion
- HIV positive,
- ≥ 4 weeks on Nevirapine or , ≥ 2 weeks on Efavirenz containing regimen,
- Supplements HAART with Moringa oleifera.
Exclusion
- Known hepatic, intestinal or renal disease,smoking, chronic alcohol ingestion, poor venous access, chronic alcohol ingestion, pregnant, smoking, on rifampicin, ketoconazole, isoniazid, breastfeeding, anaemia,vomiting
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT01410058
Start Date
January 1 2013
End Date
September 1 2013
Last Update
April 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Parirenyatwa Hospital OI Clinic
Harare, Zimbabwe